As part of a new nationwide study, vaccine giant Pfizer is recruiting 650 healthy, pregnant women between the ages of 18 and 49 and with a gestational age between 24 and 36 weeks to sign up for an experimental vaccine for RSV, or respiratory syncytial virus.
According to the U.S. National Library of Medicine's official clinical trials website, Pfizer is the study's sponsor, and the goal is to see how the experimental vaccine for RSV will affect unborn babies' health, either good or bad.
"The SAVVY study is assessing the safety of an investigational RSV vaccine given to healthy pregnant women," reads a portion of the descriptor that's been assigned to this research project by Pfizer.
"The study will also measure immune system response to a single study injection to evaluate the role the investigational vaccine may potentially play in protecting a baby's health," it goes on to explain.
For more vaccine-related news, be sure to check out Vaccines.news.
RSV is "a relatively mild, cold-like illness that clears up in a week or two – do we REALLY need a vaccine for it?
Pfizer is testing not just one but four different experimental vaccines for RSV, some of which contain aluminum hydroxide, a deadly neurotoxin that's been linked to causing Gulf War Syndrome (GWS).
The healthy, pregnant women who agree to participate in Pfizer's study will receive one of these four experimental RSV vaccines or a placebo, "with our without aluminum hydroxide," the study indicates.
These expectant mothers will be instructed to "record their temperature and any vaccination-site swelling or redness in an electronic diary (e-diary) for 7 consecutive days at home beginning the day of vaccination," the parameters further reveal.
At 88 different test locations in 19 different states, these women will continue to participate in the trial for an entire year after delivering their babies – assuming these babies survive – by going in for five scheduled visits, as well as additional visits beyond that if necessary.
More Americans are waking up and asking: Why should we agree to be human guinea pigs for the vaccine industry?
One of the test locations, the Diagnostic Clinic of Longview in Texas, proudly announced its partnership with Pfizer on Facebook, prompting massive backlash from users, many of whom asked things like:
"Who in their right mind would subject their healthy baby to an experimental vaccine?"
Another asked:
"Why in the world would anyone allow their unborn child to be a test subject?!"
The Diagnostic Clinic of Longview was quick to remove the post after receiving hundreds of comments along these same lines. Such backlash is indicative that more and more Americans are waking up to the vaccine industry's crimes against humanity, which include experimenting on healthy, pregnant women to push more of its deadly vaccines on the public.
It's important to note that vaccine giant Novavax, in collaboration with the Bill & Melinda Gates Foundation, performed a similar clinical trial on an RSV F vaccine, which was tested on 4,600 participants. With a grant of nearly $90 million from the Bill & Melinda Gates Fund, this trial was completed in July.
Perhaps this is all part of what Bill Gates was referring to at that infamous TED Talk he gave back in 2010, during which Gates openly admitted that vaccines are an important part of the globalists' plan to massively reduce the world's population in the name of "saving the planet" from "climate change" and "global warming."
Sources for this article include:
Please contact us for more information.
